ImmunityBio resubmits cancer treatment application to FDA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/30/2026

1. DLR
2. SPY
3. EOSE
4. AVAV
5. MU
6. ENPH
7. VSH
8. CNXC
9. LOGI
10. ASTC

Go back to ImmunityBio resubmits cancer treatment application to FDA
(NASDAQ: IBRX) Delayed: 8.75 -0.02 (0.23%)
Previous Close $8.77    52 Week High $ 
Open $8.80    52 Week Low $ 
Day High $9.00    P/E N/A 
Day Low $8.61    EPS $ 
Volume 1,735,163